TRIGLYCERIDES_2 REAGENT, CONCENTRATED 10697575

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional,user faci report with the FDA on 2016-02-05 for TRIGLYCERIDES_2 REAGENT, CONCENTRATED 10697575 manufactured by Siemens Healthcare Diagnostics, Inc..

Event Text Entries

[37576435] Siemens technical operations has confirmed that the trig_c assay reagent lot 338040 is not linear to the instructions for use (ifu) claim of 550 mg/dl (62. 15 mmol/l). Siemens diagnostics is investigating this issue.
Patient Sequence No: 1, Text Type: N, H10


[37576436] The customer observed that linearity samples were not meeting specifications when using triglyceride_2 concentrated reagent lot 338040 on an advia 1800 chemistry system. The samples were run in triplicates and compared to the target value. Customer has observed that the assay is linear up to 450 mg/dl. The customer ran the linearity samples with another reagent lot for trig_c and the results were within specifications. None of the results from the linearity samples were released to the physician(s) there were no reports of patient intervention or adverse health consequences due to the linearity samples not meeting specifications.
Patient Sequence No: 1, Text Type: D, B5


[42038890] The initial mdr 2432235-2016-00049 was filed on 2/5/2016. Correction: the initial mdr states the date of awareness as 01/20/2106. The correct date is 01/13/2016. Additional information (2/29/2016): siemens healthcare diagnostics has confirmed the trig_c reagent kit lots 348297 and 359932( smn 10697575) used on the advia 1200, 1650, 1800, 2400, and xpt chemistry systems does not meet instructions for use (ifu) linearity claim at the upper limit of the assay range as it approaches end of shelf life. Internal testing demonstrated that a patient bias (-12% to -15%) may be seen at concentration levels between 450 to 550mg/dl. Linearity is reduced by approximately 31% at higher triglyceride concentrations up to 1200mg/dl (13. 56mmol/l). An urgent field safety notice (ufsn) chc16-03. A. Ous was sent to ous customers and a urgent medical device recall (umdr) chc16-03. A. Us was sent to us customers in march of 2016. The ufsn and umdr state that customers are to discontinue use and discard reagent kit lots 348297 and 359932.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number2432235-2016-00049
MDR Report Key5412786
Report SourceHEALTH PROFESSIONAL,USER FACI
Date Received2016-02-05
Date of Report2016-01-20
Date of Event2015-12-09
Date Mfgr Received2016-02-29
Date Added to Maude2016-02-05
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactAARTI AZIZ
Manufacturer Street511 BENEDICT AVENUE
Manufacturer CityTARRYTOWN NY 10591
Manufacturer CountryUS
Manufacturer Postal10591
Manufacturer Phone9145242683
Manufacturer G1RANDOX LABORATORIES LTD. (REG# 8020890)
Manufacturer Street55 DIAMON ROAD CRUMLIN
Manufacturer CityCO. ANTRIM, BT294QY
Manufacturer CountryUK
Manufacturer Postal CodeBT29 4QY
Single Use3
Previous Use Code3
Removal Correction Number2432235-03/09/2016-001-R
Event Type3
Type of Report3

Device Details

Brand NameTRIGLYCERIDES_2 REAGENT, CONCENTRATED
Generic NameTRIGLYCERIDES_2 REAGENT, CONCENTRATED
Product CodeCDT
Date Received2016-02-05
Model NumberTRIGLYCERIDES_2 REAGENT, CONCENTRATED
Catalog Number10697575
Lot Number338040
Device Availability*
Device AgeDA
Device Eval'ed by MfgrN
Device Sequence No1
Device Event Key0
ManufacturerSIEMENS HEALTHCARE DIAGNOSTICS, INC.
Manufacturer Address511 BENEDICT AVENUE TARRYTOWN NY 10591 US 10591


Patients

Patient NumberTreatmentOutcomeDate
10 2016-02-05

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.